Immunohistochemistry images of colon cancer tissues and study of the TCGA (The Cancer Genome Atlas) database both implied the reduction of SLC35C1 and elevation of β‐catenin in all stages of colon cancer. Here, SLC35C1 is linked to malignant colon neoplasm.